An observational study in Cardiac Arrhythmia, sponsored by Myant Medical Corp.. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-26.
Sponsored by Myant Medical Corp. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 73 studies in Arrhythmias, Cardiac with a site in Canada — 13 open to participants now, 15 under way, none of them phase 3. Arrhythmias, Cardiac · Canada.
Among the 73 studies in Arrhythmias, Cardiac with a site in Canada, this one is the 19th largest by enrollment of the 24 observational ones that give a count, is one of 5 that started in 2023, is one of 24 observational ones, and was the 65th registered.
1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.
Browse Arrhythmias, Cardiac studies →13 of the 73 studies in Arrhythmias, Cardiac with a site in Canada are open now. Recruiting first, the newest first:
Cardurion Pharmaceuticals, Inc. · Sites in Canada, United States, France and 3 more countries
Ages 18–99
Novartis Pharmaceuticals · Sites in Canada, United States, China and 4 more countries
Ages 18+
Hamilton Health Sciences Corporation · Sites in Canada
Ages 18+
Myant Medical Corp. · Sites in Canada
Ages 18+
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 18–80 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 167 Arrhythmias, Cardiac studies recruiting now, 119 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
73 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 9 · Phase 3 13 · Phase 4 3
First in 1983; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 53 is below the median of 200 across 467 observational studies indexed under Arrhythmias, Cardiac.
Median enrollment 240 across the 49 interventional studies, 172 across the 24 observational. Of the 53 that completed or were terminated, 13 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 73 have an industry lead sponsor. The 10 most frequent:
Myant Medical Corp. is the lead sponsor of 7 studies on the registry; 3 are open to participants now.
Myant Medical Corp. has 2 studies filed under Arrhythmias, Cardiac — fewer than ten, so there is no comparison to draw.
9 of the studies in Arrhythmias, Cardiac with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT04520347University of California, Los AngelesIVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry | 2026-12 |
| NCT05258422McGill University Health Centre/Research Institute of the McGill University Health CentreStereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) | 2026-12-31 |
| NCT06164808HelpWear Inc.Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch | 2026-12-31 |
| NCT06174220Hamilton Health Sciences CorporationTargeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy | 2027-02-01 |
Add all 9 to your calendar (.ics) → With an account.
Among the 73 studies in Arrhythmias, Cardiac with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to compare the electrocardiogram recording from Holter monitor with textile sensors (in the form of clothing) in patients diagnosed with arrhythmia. The study aims to answer the following questions:
Participants that need Holter monitoring as part of their standard care will be invited to participate in the study. They will simultaneously wear both, the Holter monitor and the textile sensors for the time prescribed by their physician. Participants will also be asked to answer a questionnaire in the initial assessment and at the end of the study.
adults with cardiovascular disease and/or risks justifying the need for performing an ECG Holter
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants enrolled will wear simultaneously the PocketECG (Standard Holter) and the Skiin Underwear Chestband (wearable textile). Each participant will wear both systems for the duration prescribed by their physician (1 to 14 days).
Also known as: PocketECG
Difference in Usable ECG
The duration of diagnostic ECG from PocketECG minus the duration of diagnostic ECG from Skiin underwear
Time frame: Throughout the entire data collection period, that is between 1 and 14 days
Difference in Heart Rate
The heart rate obtained from PocketECG minus the heart rate obtained from Skiin underwear
Time frame: Throughout the entire data collection period, that is between 1 and 14 days
Difference in RR intervals
The RR intervals obtained from PocketECG minus the RR intervals obtained from Skiin underwear
Time frame: Throughout the entire data collection period, that is between 1 and 14 days
Arrhythmic events
The number and proportion of arrhythmic events obtained by PocketECG and by Skiin underwear
Time frame: Throughout the entire data collection period, that is between 1 and 14 days
Patient's perception
A questionnaire developed by Myant containing 10 questions related to the comfort, usability, ease of use and enjoyment will be applied to assess patients' perception of the Skiin underwear and of the PocketECG and to compare both systems, with answers on a 7 point Lickert Scale (from Strongly disagree to Strongly Agree, no numeric scoring).
Time frame: At the end of the study, 1 to 14 days after initiation.
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Oct 2023 to primary completion in Feb 2024, 3 months.
Of 69 industry-sponsored observational studies under Arrhythmias, Cardiac, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 51. This study's 3 months is below that.
Counting every sponsor, half of 259 studies reached it within 38 months; a quarter within 16 and three quarters within 97.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Myant Medical Corp.